Dianthus Therapeutics (DNTH) EBT Margin (2022 - 2025)
Dianthus Therapeutics (DNTH) recorded quarterly EBT Margin of 9250.0% in Q3 2025, up 43.37% quarter-over-quarter from 16333.68% in Q2 2025, and down 797026.0% on a YoY basis from N/an in Q3 2024.
Dianthus Therapeutics (DNTH) EBT Margin (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' EBT Margin history runs 4 years deep, the most recent figure standing at 9250.0% for Q3 2025.
- In Q3 2025, EBT Margin fell 797026.0% year-over-year to 9250.0%; the TTM figure through Sep 2025 stood at 4027.8% (down 270885.0% YoY), while the FY2024 annual figure was 1355.24%, up 18086.0% from the prior year.
- EBT Margin was 9250.0% for Q3 2025 at Dianthus Therapeutics, up from 16333.68% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 668.2% in Q3 2022 to a low of 16333.68% in Q2 2025.
- Historically, EBT Margin has averaged 3248.8% across 4 years, with a median of 1617.85% in 2024.
- The sharpest annual moves came in 2024 and 2025: EBT Margin soared 36157 bps in 2024, then slumped 1537190 bps in 2025.
- A 4-year view of EBT Margin shows it stood at 868.13% in 2022, then sank by 184 bps to 2467.61% in 2023, then increased by 15 bps to 2106.03% in 2024, then sank by 339 bps to 9250.0% in 2025.
- The last three EBT Margin figures came in at 9250.0% (Q3 2025), 16333.68% (Q2 2025), and 2448.83% (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.60 Bn | 3.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -9,250.00% |
| Jun 30, 2025 | -16,333.68% |
| Mar 31, 2025 | -2,448.83% |
| Dec 31, 2024 | -2,106.03% |
| Sep 30, 2024 | -1,279.74% |
| Jun 30, 2024 | -961.78% |
| Mar 31, 2024 | -1,617.85% |
| Dec 31, 2023 | -2,467.61% |
| Sep 30, 2023 | -1,636.89% |
| Jun 30, 2023 | -1,108.90% |
| Mar 31, 2023 | -1,486.76% |
| Dec 31, 2022 | -868.13% |
| Sep 30, 2022 | -668.20% |